160 related articles for article (PubMed ID: 24398820)
1. Rimonabant's reductive effects on high densities of food reinforcement, but not palatability, in lean and obese Zucker rats.
Buckley JL; Rasmussen EB
Psychopharmacology (Berl); 2014 May; 231(10):2159-70. PubMed ID: 24398820
[TBL] [Abstract][Full Text] [Related]
2. Impulsive-choice patterns for food in genetically lean and obese Zucker rats.
Boomhower SR; Rasmussen EB; Doherty TS
Behav Brain Res; 2013 Mar; 241():214-21. PubMed ID: 23261877
[TBL] [Abstract][Full Text] [Related]
3. Rimonabant reduces the essential value of food in the genetically obese Zucker rat: an exponential demand analysis.
Rasmussen EB; Reilly W; Buckley J; Boomhower SR
Physiol Behav; 2012 Feb; 105(3):734-41. PubMed ID: 22019829
[TBL] [Abstract][Full Text] [Related]
4. Obese and lean Zucker rats demonstrate differential sensitivity to rates of food reinforcement in a choice procedure.
Buckley JL; Rasmussen EB
Physiol Behav; 2012 Dec; 108():19-27. PubMed ID: 23046726
[TBL] [Abstract][Full Text] [Related]
5. Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats.
Rasmussen EB; Huskinson SL
Behav Pharmacol; 2008 Oct; 19(7):735-42. PubMed ID: 18797250
[TBL] [Abstract][Full Text] [Related]
6. The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food.
Dore R; Valenza M; Wang X; Rice KC; Sabino V; Cottone P
Addict Biol; 2014 Sep; 19(5):849-61. PubMed ID: 23587012
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard-chow diets.
Boomhower SR; Rasmussen EB
Behav Pharmacol; 2014 Dec; 25(8):705-16. PubMed ID: 25000488
[TBL] [Abstract][Full Text] [Related]
8. Demand for sucrose in the genetically obese Zucker (fa/fa) rat.
Rasmussen EB; Reilly W; Hillman C
Behav Processes; 2010 Oct; 85(2):191-7. PubMed ID: 20674704
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a shortened model of diet alternation in female rats: effects of the CB1 receptor antagonist rimonabant on food intake and anxiety-like behavior.
Blasio A; Rice KC; Sabino V; Cottone P
Behav Pharmacol; 2014 Oct; 25(7):609-17. PubMed ID: 25011007
[TBL] [Abstract][Full Text] [Related]
10. Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding.
Freedland CS; Poston JS; Porrino LJ
Pharmacol Biochem Behav; 2000 Oct; 67(2):265-70. PubMed ID: 11124390
[TBL] [Abstract][Full Text] [Related]
11. Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates.
Foltin RW; Haney M
Pharmacol Biochem Behav; 2007 Apr; 86(4):766-73. PubMed ID: 17445873
[TBL] [Abstract][Full Text] [Related]
12. AM 251 differentially effects food-maintained responding depending on food palatability.
Droste SM; Saland SK; Schlitter EK; Rodefer JS
Pharmacol Biochem Behav; 2010 Jun; 95(4):443-8. PubMed ID: 20331999
[TBL] [Abstract][Full Text] [Related]
13. The effect of naloxone on food-motivated behavior in the obese Zucker rat.
Glass MJ; O'Hare E; Cleary JP; Billington CJ; Levine AS
Psychopharmacology (Berl); 1999 Feb; 141(4):378-84. PubMed ID: 10090645
[TBL] [Abstract][Full Text] [Related]
14. Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats.
Hernandez G; Cheer JF
J Neurosci; 2012 Aug; 32(33):11467-77. PubMed ID: 22895729
[TBL] [Abstract][Full Text] [Related]
15. Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats.
Doyon C; Denis RG; Baraboi ED; Samson P; Lalonde J; Deshaies Y; Richard D
Diabetes; 2006 Dec; 55(12):3403-10. PubMed ID: 17130486
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.
Mathes CM; Ferrara M; Rowland NE
Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R67-75. PubMed ID: 18448611
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.
Sink KS; Vemuri VK; Olszewska T; Makriyannis A; Salamone JD
Psychopharmacology (Berl); 2008 Mar; 196(4):565-74. PubMed ID: 18004546
[TBL] [Abstract][Full Text] [Related]
18. Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure.
Marusich JA; Wiley JL
Pharmacol Biochem Behav; 2012 Jun; 101(4):575-80. PubMed ID: 22425597
[TBL] [Abstract][Full Text] [Related]
19. Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task.
Salamone JD; Arizzi MN; Sandoval MD; Cervone KM; Aberman JE
Psychopharmacology (Berl); 2002 Apr; 160(4):371-80. PubMed ID: 11919664
[TBL] [Abstract][Full Text] [Related]
20. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
